Randomized trials in the treatment of Barrett's esophagus

Diseases of the Esophagus

Volumn 18, Issue 5, 2005, Pages 291-297

  Faybush, E M ^a   Sampliner, Richard E ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Anti reflux surgery; Barrett's esophagus; Endoscopic ablation; Esophageal adenocarcinoma; Proton pump inhibitor

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE; PROTON PUMP;

ANTIREFLUX OPERATION; BARRETT ESOPHAGUS; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; ESOPHAGEAL ADENOCARCINOMA; HUMAN; INTERMETHOD COMPARISON; MEDLINE; META ANALYSIS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; SAFETY; SAMPLE SIZE; STOMACH FUNDOPLICATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; CONTROLLED CLINICAL TRIAL; DIGESTIVE TRACT ENDOSCOPY; DRUG ANTAGONISM; ELECTROCOAGULATION; PHOTOCHEMOTHERAPY; RANDOMIZED CONTROLLED TRIAL;

BARRETT ESOPHAGUS; ELECTROCOAGULATION; ENDOSCOPY, DIGESTIVE SYSTEM; FUNDOPLICATION; HUMANS; PHOTOCHEMOTHERAPY; PROTON PUMPS; RANDOMIZED CONTROLLED TRIALS;

EID: 33644877122     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2005.00503.x     Document Type: Review

References (21)

1. Sampliner R E, Practice Parameters Committee ACG. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002; 97: 1888-95.
2. Drewitz D J, Sampliner R E, Garewal H S. The incidence of adenocarcinoma in Barrett's esophagus - a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997; 92: 212-15.
3. Shaheen N J, Crosby M A, Bozymski E M. Is there publication bias in the reporting of cancer risk of Barrett's esophagus? Gastroenterology 2000; 119: 333-8.
4. Blot W, Devesa S S, Kneller R W, Fraumeni J F. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-9.
5. Brown L M, Devesa S S. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002; 11: 235-56.
6. Eisen G M. Ablation therapy for Barrett's esophagus. Gastrintest Endosc 2003; 58: 760-9.
7. Gross G P, Canto M I, Hixson J, Powe N R. Management of Barrett's esophagus: A national study of practice patterns and their cost implications. Am J Gastroenterol 1999; 94: 3440-7.
8. Spechler S J, Goyal R K. Barrett's esophagus. N Engl J Med 1986; 315: 362-71.
9. Peters F T M, Ganesh S, Kuipers E J et al. Endoscopic regression of Barrett's oesophagus during omeprazole treatment: A randomised double blind study. Gut 1999; 45: 489-94.
10. Parilla P, Martinez de Haro L, Ortiz A et al. Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus. Ann Surg 2003; 237: 291-8.
11. Overholt B F, Panjehpour M, Haydek J M. Photodynamic therapy for Barrett's esophagus: Follow-up in 100 patients. Gastrointest Endosc 1999; 49: 1-7.
12. Messmann H, Knuchel Baumler W, Holstege A, Scholmerich J. Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization. Gastrointest Endosc 1999; 49: 97-101.
13. Schulz H, Miehlke S, Antos D et al. Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole. Gastrointest Endosc 2000; 51: 659-63.
14. Sampliner R E, Faigel D, Fennerty M B et al. Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: A multicenter study. Gastrointest Endosc 2001; 53: 554-8.
15. Ackroyd R, Brown N J, Davis M F et al. Photodynamic therapy for dysplastic Barrett's oesophagus: A prospective, double blind, randomised, placebo controlled trial. Gut 2000; 47: 612-17.
16. Overholt B, Lightdale C, Wang K et al. International, multicenter, partially blinded, randomised study of the efficacy of photodynamic therapy (PDT) using porfimer sodium (POR) for the ablation of high-grade dysplasia (HGD) in Barrett's esophagus (BE): Results of 24-month follow-up. Gastroenterology 2003; 124: A20.
17. Ackroyd R, Tam W, Schoeman M, Devitt P G, Watson D I. Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett's esophagus after antireflux surgery. Gastrintest Endosc 2004; 59: 1-7.
18. Hage M, Siersema P D, van Dekken H et al. 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: A randomised trial. Gut 2004; 53: 785-90.
19. Kelty C, Ackroyd R, Brown N J, Stephenson T J, Stoddard C J, Reed M W R. Endoscopic ablation of Barrett's oesophagus: A randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation. Aliment Pharmacol Ther 2004; 20: 1289-96.
20. Dulai G S, Jensen D M, Cortina G, Fontana L, Ippoliti A. Randomized trial of argon plasma coagulation versus multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrintest Endosc 2005; 61: 232-40.
21. Sharma P, Morales T G, Sampliner R E. Short segment Barrett's esophagus: the need standardization of the definition and of endoscopic criteria. Am J Gastroenterol 1998; 93: 1033-6.